Advocates in New York are calling on lawmakers to support a series of bills that would decriminalize psilocybin-containing mushrooms and promote their medical use. The push comes after Massachusetts voters rejected a similar measure, leaving New York with an opportunity to lead the region in psychedelic medicine policy.

Mental health and psychedelic-supporting advocates, including pharmacists, community leaders, and mushroom farmers, were meeting with lawmakers on Tuesday to discuss the potential benefits of legalizing psilocybin. They argue that a regulated system could provide safe and affordable access to those in need, particularly veterans and first responders dealing with conditions such as cluster headaches, depression, and chronic pain.

Four Bills to Shape New York’s Psychedelic Policy

The proposed legislation would:

• Decriminalize psilocybin-containing mushrooms and other natural psychedelics.
• Establish a medical distribution model.
• Create a pilot program for veterans and first responders.
• Implement a licensing system requiring individuals to complete a course and pass an exam before growing or purchasing psilocybin mushrooms.

Avery Stempel, Co-President of New Yorkers for Mental Health Alternatives, emphasized the differences between this initiative and New York’s cannabis rollout.

“Many cannabis users are daily or weekly users. Psilocybin-containing mushrooms are a little different, and people don’t typically overuse that substance that promotes neuroplasticity in that way,” Stempel explained. “So the market that is being created is going to be for therapists or counselors to be able to lead people through experiences.”

Affordability and Accessibility at the Forefront

Affordability remains a key concern. Massachusetts’ failed initiative faced criticism for its high costs, with therapy sessions priced at hundreds of dollars. New York advocates want to ensure that cost does not become a barrier.

One bill, which is supported by Assemblyperson Amy Paulin, would cap the cost of the required course and exam at $150. It would also allow individuals to cultivate psilocybin at home using readily available mushroom-growing supplies, making the treatment more accessible.

“In order to take the course, we’re limiting the cost of that course and the cost of the exam to less than $150,” Stempel said. “Once you’re approved to grow or purchase…you can acquire some growth supplies. It does not take a lot of space for you to produce your own supply of these substances.”

A New Agricultural Opportunity for New York

Psilocybin legalization could also open up new agricultural opportunities. Farmers across the state are eager to introduce psilocybin mushrooms as a viable crop by 2025.

Despite little pushback from lawmakers, the focus remains on implementing proper regulations and safety measures. Advocates aim to secure enough legislative support to bring the bills to the statehouse floor for a vote.

For continued coverage of this developing story, visit 13 Investigates at WNYT.com.